Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Decitabine Is More Cost Effective Than Standard Conventional Induction Therapy In Elderly Acute Myeloid Leukemia Patients

Nicolas Batty, MD, Samuel Wiles, Mathew Kabalan, Rohit Sharma, MD, Joseph Shatzel, MD, Jonathan Pang, David Yi, Iris Alatovic, Sana Saif, MD, Deepika Narasimha, Joseph LaPenna, Anthony Troitino, MD, Kristopher Attwood, MS, Yong Yin, PhD, Meir Wetzler, MD

Blood (2013) 122 (21): 2699.

https://doi.org/10.1182/blood.V122.21.2699.2699

Published: 2013

Journal Articles

Blood Transfusion and Erythropoiesis Stimulating Agents (ESAs) Use In Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Nicolas Batty, MD, Elham Ghonimi, MD, Lei Feng, PhD, Anas Younes, MD, Rodriguez Alma, MD, Elizabeth Wager, MD, Fernando Martinez, MD, MPH, Michael Wang, MD, Peter McLaughlin, MD, Nathan Fowler, MD, Fredrick Hagemeister, MD

Blood (2010) 116 (21): 3357.

https://doi.org/10.1182/blood.V116.21.3357.3357

Published: 2010

Journal Articles

Pretreatment Factors Associated with Second Malignancies Occuring After Frontline Fludarabine, Cyclophosphamide, and Rituximab (FCR) in Patients with Chronic Lymphocytic Leukemia (CLL).

Nicolas Batty, MD, Xavier C. Badoux, MBBS, Michael Keating, MD, E. Lin, Susan Lerner, M.S., RHIA, Susan O'Brien, Alessandra Ferrajoli, MD., Tapan Kadia, MD, Jan A. Burger, MD, PhD, Stefan Faderl, MD, William G. Wierda, M.D., Ph.D

Blood (2009) 114 (22): 3448.

https://doi.org/10.1182/blood.V114.22.3448.3448

Published: 2009

Journal Articles

Patients with Chronic Myeloid Leukemia with Variant Philadelphia Chromosome (Ph) Translocations Have a Similar Outcome as Those with Classic Ph When Treated with Imatinib or 2 nd Generation TKI

Nicolas Batty, Hagop Kantarjian, Gautam Borthakur, Farhad Ravandi, Susan O’Brien, Zeev Estrov, Jianqin Shan, Srdan Verstovsek, Jorge Cortes

Blood (2008) 112 (11): 3228.

https://doi.org/10.1182/blood.V112.11.3228.3228

Published: 2008

Journal Articles

Epidemiology and Clinical Outcomes of the M-Component Immunoglobulin Types of Multiple Myeloma in an Inner City Hispanic Population.

George Nicolas Batty, MD, AACP, Jonathan Brower, Adel Aziz, MD, Neelima Maddukuri, MD, James Tadros, MD, Kyudong Uhm, MD, Michael Maroules, MD

Blood (2007) 110 (11): 4736.

https://doi.org/10.1182/blood.V110.11.4736.4736

Published: 2007

NARROW

Decitabine Is More Cost Effective Than Standard Conventional Induction Therapy In Elderly Acute Myeloid Leukemia Patients

Blood Transfusion and Erythropoiesis Stimulating Agents (ESAs) Use In Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Pretreatment Factors Associated with Second Malignancies Occuring After Frontline Fludarabine, Cyclophosphamide, and Rituximab (FCR) in Patients with Chronic Lymphocytic Leukemia (CLL).

Patients with Chronic Myeloid Leukemia with Variant Philadelphia Chromosome (Ph) Translocations Have a Similar Outcome as Those with Classic Ph When Treated with Imatinib or 2 nd Generation TKI

Epidemiology and Clinical Outcomes of the M-Component Immunoglobulin Types of Multiple Myeloma in an Inner City Hispanic Population.

Email alerts

ASH Publications

American Society of Hematology

Decitabine Is More Cost Effective Than Standard Conventional Induction Therapy In Elderly Acute Myeloid Leukemia Patients

Blood Transfusion and Erythropoiesis Stimulating Agents (ESAs) Use In Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Pretreatment Factors Associated with Second Malignancies Occuring After Frontline Fludarabine, Cyclophosphamide, and Rituximab (FCR) in Patients with Chronic Lymphocytic Leukemia (CLL).

Patients with Chronic Myeloid Leukemia with Variant Philadelphia Chromosome (Ph) Translocations Have a Similar Outcome as Those with Classic Ph When Treated with Imatinib or 2 nd Generation TKI

Epidemiology and Clinical Outcomes of the M-Component Immunoglobulin Types of Multiple Myeloma in an Inner City Hispanic Population.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only